Avantis Medical Systems, Inc., the Sunnyvale, Calif. based creator of the Third Eye Retroscope–a device that adds an extra view to a colonoscope, has raised $3,048,468 of venture capital to further commercialize its flagship product in the U.S., make small improvements to the product, as well as using a “little bit” work toward earning a CE Mark in Europe, President and CEO Tony DiTonno said.
The company, in Series D funding, seeks about $4.95 million more, according to the regulatory filing it made with the SEC.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
DiTonno said he expects the company to be acquired in 18 months to two years.
The officers and directors listed on the filing include DiTonno, who previously served as CEO for NeurogesX and LifeSleep; Director Dr. Thomas Fogarty; former Director Matthew Jenusaitis; Director Dr. Camran Nezhat, a general partner at CN Investment; Director Howard Palefsky, managing director at Montreux Equity Partners; and Director Dr. John Savarese, also a managing director at Montreux Equity.
